Skip to main content
SpringerLink
Log in

The Role of Neuropilin in Vascular and Tumor Biology

  • Chapter
Book cover Neuropilin: From Nervous System to Vascular and Tumor Biology

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 515))

Abstract

Neuropilin-1 (NRP 1) and NRP2 are related transmembrane receptors that function as mediators of neuronal guidance and angiogenesis. NRPs bind members of the class 3 semaphorin family, regulators of neuronal guidance, and of the vascular endothelial growth factor (VEGF) family of angiogenesis factors. There is substantial evidence that NRPs serve as mediators of developmental and tumor angiogenesis. NRPs are expressed in endothelial cells (EC) and bind VEGF165. NRP1 is a co-receptor for VEGF receptor-2 (VEGFR2) that enhances the binding of VEGF165 to VEGFR2 and VEGF165-mediated chemotaxis. NRP1 expression is regulated in EC by tumor necrosis factor-α, the transcription factors dHAND and Ets- 1, and vascular injury. During avian blood vessel development NRP I is expressed only in arteries whereas NRP2 is expressed in veins. Transgenic mouse models demonstrate that NRP1 plays a critical role in embryonic vascular development. Overexpression of NRP 1 results in the formation of excess capillaries and hemorrhaging. NRP1 knockouts have defects in yolk sac, embryo and neuronal vascularization, and in development of large vessels in the heart. Tumor cells express NRPs and bind VEGF165. NRP1 upregulation is positively correlated with the progression of various tumors. Overexpression of NRP 1 in rat tumor cells results in enlarged tumors and substantially enhanced tumor angiogenesis. On the other hand, soluble NRP1 (sNRP 1) is an antagonist of tumor angiogenesis. Semaphorin 3A binds to EC and tumor cells. It also inhibits EC motility and capillary sprouting in vitro. VEGF165

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fujisawa H, Kitsukawa, T. Receptors for collapsin/semaphorins. Curr Opin Neurobiol 1998; 8:587–592.

    Article  PubMed  CAS  Google Scholar 

  2. Neufeld G, Cohen T, Gengrinovitch S et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13:9–22.

    PubMed  CAS  Google Scholar 

  3. Shima D, Mailhos C. Vascular development biology: getting nervous. Curr Opin Genet Dev 2000; 10:536–542.

    Article  PubMed  CAS  Google Scholar 

  4. Raper JA. Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 2000; 10:88–94.

    Article  PubMed  CAS  Google Scholar 

  5. Miao HQ, Klagsbrun M. Neuropilin is a mediator of angiogenesis. Cancer Metastasis Rev 2000; 19:29–37.

    Article  PubMed  CAS  Google Scholar 

  6. Soker S. Neuropilin in the midst of cell migration and retraction. Int J Oncol 2001; 33:433–437.

    CAS  Google Scholar 

  7. Takagi S, Kasuya Y, Shimizu M et al. Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system. Dev Biol 1995; 170:207–222.

    Article  PubMed  CAS  Google Scholar 

  8. Kawakami A, Kitsukawa T, Takagi S et al. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol 1996; 29:1–17.

    Article  PubMed  CAS  Google Scholar 

  9. Fujisawa H, Kitsukawa T, Kawakami A et al. Roles of a neuronal cell-surface molecule, neuropilin, in nerve fiber fasciculation and guidance. Cell Tissue Res 1997; 290:465–470.

    Article  PubMed  CAS  Google Scholar 

  10. Kolodkin AL, Levengood DV, Rowe EG et al. Neuropilin is a semaphorin III receptor. Cell 1997; 90:753–762.

    Article  PubMed  CAS  Google Scholar 

  11. Kitsukawa T, Shimono A, Kawakami A et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 1995; 121:4309–4318.

    PubMed  CAS  Google Scholar 

  12. Soker S, Takashima S, Miao HQ et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92:735–745.

    Article  PubMed  CAS  Google Scholar 

  13. Gagnon ML, Bielenberg DR, Gechtman Z et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. Proc Nati Acad Sci USA 2000; 97:2573–2578.

    Article  CAS  Google Scholar 

  14. Rossignol M, Gagnon ML, Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms, Genomics 2000; 70:211–222.

    Article  PubMed  CAS  Google Scholar 

  15. Pavelock K, Braas K, Ouafik L et al. Differential expression and regulation of the vascular endothelial growth factor receptors neuropilin-1 and neuropilin-2 in rat uterus. Endocrinology 2001; 142:613–622.

    Article  PubMed  CAS  Google Scholar 

  16. Eickholt BJ, Mackenzie SL, Graham A et al. Evidence for collapsin-1 functioning in the control of neural crest migration in both trunk and hindbrain regions. Development 1999; 126:2181–2189.

    PubMed  CAS  Google Scholar 

  17. Deckers MM, Karperien M, van der Bent C et al. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000; 141:1667–1674.

    Article  PubMed  CAS  Google Scholar 

  18. Harper J, Gerstenfeld LC, Klagsbrun M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 2001; 81:82–92.

    Article  PubMed  CAS  Google Scholar 

  19. Tordjman R, Ortega N, Coulombel L et al. Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells? Blood 1999; 94:2301–2309.

    PubMed  CAS  Google Scholar 

  20. Thomas S, Vanuystel J, Gruden G et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 2000; 11:1236–1243.

    PubMed  CAS  Google Scholar 

  21. Cohen T, Gluzman-Poltorak Z, Brodzky A et al. Neuroendocrine cells along the digestive tract express neuropilin-2. Biochem Biophys Res Commun 2001; 284:395–403.

    Article  PubMed  CAS  Google Scholar 

  22. Harper SJ, Xing CY, Whittle C et al. Expression of neuropilin-I by human glomerular epithelial cells in vitro and in vivo. Clin Sci 2001; 101:439–446.

    Article  PubMed  CAS  Google Scholar 

  23. Cai H, Reed RR. Cloning and characterization of neuropilin-l-interacting protein: a PSD-95/ Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J Neurosci 1999; 19:6519–6527.

    PubMed  CAS  Google Scholar 

  24. Rossignol M, Beggs AH, Pierce EA et al. Human neuropilin-1 and neuropilin-2 map to 10p12 and 2q34, respectively. Genomics 1999; 57:459–460.

    Article  PubMed  CAS  Google Scholar 

  25. He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997; 90:739–751.

    Article  PubMed  CAS  Google Scholar 

  26. Chen H, Chedotal A, He Z et al. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 1997; 19:547–559.

    CAS  Google Scholar 

  27. Chen H, He Z, Bagri A et al. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Neuron 1998; 21:1283–1290.

    Article  PubMed  CAS  Google Scholar 

  28. Takahashi T, Nakamura F, Jin Z et al. Semaphorins A and E act as antagonists of neuropilin-I and agonists of neuropilin-2 receptors. Nat Neurosci 1998; 1:487–493.

    Article  PubMed  CAS  Google Scholar 

  29. Giger RJ, Urquhart ER, Gillespie SK et al. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 1998; 21:1079–1092.

    Article  PubMed  CAS  Google Scholar 

  30. Luo Y, Raible D, Raper JA. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 1993; 75:217–227.

    Article  PubMed  CAS  Google Scholar 

  31. Marin O, Yaron A, Bargri A et al. Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions. Science 2001; 293:872–875.

    Article  PubMed  CAS  Google Scholar 

  32. Winberg ML, Noordermeer JN, Tamagnone L et al. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell 1998; 95:903–916.

    Article  PubMed  CAS  Google Scholar 

  33. Tamagnone L, Artigiani S, Chen H et al. Plexins are a large family of receptors for trans-membrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99:71–80.

    Article  PubMed  CAS  Google Scholar 

  34. Tamagnone L, Comoglio PM. Signaling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol 2000; 10:377–383.

    Article  PubMed  CAS  Google Scholar 

  35. Castellani V, Chedotal A, Schachne, M et al. Analysis of the LI-deficient mouse phenotype reveals cross-talk between Sema3A and LI signaling pathways in axonal guidance. Neuron 2000; 27:237–249.

    Article  PubMed  CAS  Google Scholar 

  36. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 77:527–543.

    Article  PubMed  CAS  Google Scholar 

  37. Dvorak HF, Nagy JA, Feng D et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curt Top Microbiol Immunol 1999; 237:97–132.

    Article  CAS  Google Scholar 

  38. Soker S, Fidder H, Neufeld G et al. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 1996; 271:5761–5767.

    Article  PubMed  CAS  Google Scholar 

  39. Gluzman-Poltorak Z, Cohen T, Herzog Y et al. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem 2000; 275:29922.

    Article  PubMed  CAS  Google Scholar 

  40. Migdal M, Huppertz B, Tessler S et al. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 1998; 273:22272–22278.

    Article  PubMed  CAS  Google Scholar 

  41. Makinen T, Olofsson B, Karpanen T et al. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-l. J Biol Chem 1999; 274:21217–21222.

    Article  PubMed  CAS  Google Scholar 

  42. Wise LM, Veikkola T, Mercer AA et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 1999; 96:3071–3076.

    Article  PubMed  CAS  Google Scholar 

  43. Savory LJ, Stacker SA, Fleming SB et al. Viral vascular endothelial growth factor plays a critical role in orf virus infection. J Virol 2000; 74:10699–10706.

    Article  PubMed  CAS  Google Scholar 

  44. Karkkainen MJ, Saaristo A, Jussila L et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 2001; 98:12677–12682.

    Article  PubMed  CAS  Google Scholar 

  45. Fuh G, Garcia KC, de Vos AM. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem 2000; 275:26690–26695.

    PubMed  CAS  Google Scholar 

  46. Whitaker GB, Limberg BJ, Rosenbaum JS. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(12l). J Biol Chem 2001; 276:25520–25531.

    Article  PubMed  CAS  Google Scholar 

  47. Gluzman-Poltorak Z, Cohen T, Shibuya M et al. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem 2001; 276:18688–18694.

    Article  PubMed  CAS  Google Scholar 

  48. Miao HQ, Soker S, Feiner L et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999; 146:233–242.

    PubMed  CAS  Google Scholar 

  49. Partanen TA, Makinen T, Arola J et al. Endothelial growth factor receptors in human fetal heart. Circulation 1999; 100:583–586.

    Article  PubMed  CAS  Google Scholar 

  50. Robert B, Zhao X, Abrahamson DR. Coexpression of neuropilin-1, Flkl, and VEGF(164) in developing and mature mouse kidney glomeruli. Am I Physiol 2000; 279:F275–F282.

    CAS  Google Scholar 

  51. Ishida A, Murray J, Saito Y et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 2001; 188:359–368.

    Article  PubMed  CAS  Google Scholar 

  52. Adams RH, Wilkinson GA, Weiss C et al. Roles of ephrinB ligands and EphB recceptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999; 13:295–306.

    Article  PubMed  CAS  Google Scholar 

  53. Moyon D, Pardanaud L, Yuan L et al. Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 2001; 128:3359–3370.

    PubMed  CAS  Google Scholar 

  54. Herzog Y, Kalcheim C, Kahane N et al. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 2001; 109:115–119.

    Article  PubMed  CAS  Google Scholar 

  55. Stalmans I, Ng YS, Rohan R et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109:327–336.

    PubMed  CAS  Google Scholar 

  56. Giraudo E, Primo L, Audero E et al. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-I in human vascular endothelial cells. J Biol Chem 1998; 273:22128–22135.

    Article  PubMed  CAS  Google Scholar 

  57. Yamagishi H, Olson EN, Srivastava D. The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. J Clin Invest 2000; 105:261–270.

    Article  PubMed  CAS  Google Scholar 

  58. Sato Y, Abe M, Tanaka K et al. Signal transduction and transcriptional regulation of angiogenesis. Adv Exp Med Biol 2000; 476:109–115.

    Article  PubMed  CAS  Google Scholar 

  59. Teruyama K, Abe M, Nakano T et al. Neurophilin-1 is a downstream target of transcription factor Ets-1 in human umbilical vein endothelial cells. FEBS Lett 2001; 504:1–4.

    Article  PubMed  CAS  Google Scholar 

  60. Wernert N, Raes MB, Lassalle P et al. c-etsl proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am I Pathol 1992; 140:119–127.

    CAS  Google Scholar 

  61. Kitsukawa T, Shimizu M, Sanbo M et al. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 1997; 19:995–1005.

    Article  PubMed  CAS  Google Scholar 

  62. Kawasaki T, Kitsukawa T, Bekku Y et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999; 126:4895–4902.

    PubMed  CAS  Google Scholar 

  63. Giger RJ, Cloutier JF, Sahay A et al. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 2000; 25:29–41.

    Article  PubMed  CAS  Google Scholar 

  64. Chen H, Bagri A, Zupicich JA et al. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 2000; 25:43–56.

    Article  PubMed  Google Scholar 

  65. Takashima S, Kitakaze M, Asakura M et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 2002; 99:(in press).

    Google Scholar 

  66. Yamada Y, Takakura N, Yasue H et al. Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis. Blood 2001; 97:1671–1678.

    Article  PubMed  CAS  Google Scholar 

  67. Bagnard D, Vaillant C, Khuth ST et al. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 2001; 21:3332–3341.

    PubMed  CAS  Google Scholar 

  68. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-I receptor. Eur J Neurosci 2000; 12:4243–4254.

    Article  PubMed  CAS  Google Scholar 

  69. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000; 97:10242–10247.

    Article  PubMed  CAS  Google Scholar 

  70. Oosthuyse B, Moons L, Storkebaum E et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28:131–138.

    Article  PubMed  CAS  Google Scholar 

  71. Shirvan A, Shina R, Ziv I et al. Induction of neuronal apoptosis by Semaphorin3A-derived peptide. Brain Res Mol Brain Res 2000; 83:81–93.

    Article  PubMed  CAS  Google Scholar 

  72. Latil A, Bieche I, Pesche S et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-I overexpression in metastatic forms. Int J Cancer 2000; 89:167–171.

    Article  PubMed  CAS  Google Scholar 

  73. Lacal PM, Failla CM, Pagani E et al. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol 2000; 115:1000–1007.

    Article  PubMed  CAS  Google Scholar 

  74. Ding H, Wu X, Roncari L et al. Expression and regulation of neuropilin-1 in human astrocytomas. Int J Cancer 2000; 88:584–592.

    Article  PubMed  CAS  Google Scholar 

  75. Handa A, Tokunaga T, Tsuchida T et al. Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol 2000; 17:291–295.

    PubMed  CAS  Google Scholar 

  76. Banerjee SK, Zoubine MN, Tran TM et al. Overexpression of vascular endothelial growth factorl64 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 2000; 16:253–260.

    PubMed  CAS  Google Scholar 

  77. Miao HQ, Lee P, Lin H et al. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 2000; 14:2532–9.

    Article  PubMed  CAS  Google Scholar 

  78. Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997; 94:8761–8766.

    Article  PubMed  CAS  Google Scholar 

  79. Bachelder R, Crago A, Chung J et al. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61:5736–5740.

    PubMed  CAS  Google Scholar 

  80. Xiang RH, Hensel CH, Garcia DK et al. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 1996; 32:39–48.

    Article  PubMed  CAS  Google Scholar 

  81. Roche J, Boldog F, Robinson M et al. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 1996; 12:1289–1297.

    PubMed  CAS  Google Scholar 

  82. Sekido Y, Bader S, Latif F et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 1996; 93:4120–4125.

    Article  PubMed  CAS  Google Scholar 

  83. Brambilla E, Constantin B, Drabkin H et al. Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. Am J Pathol 2000; 156:939–950.

    Article  PubMed  CAS  Google Scholar 

  84. Tomizawa Y, Sekido Y, Kondo M et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 2001; 98:13954–13959.

    Article  PubMed  CAS  Google Scholar 

  85. Tse C, Xiang RH, Bracht T et al. Human Semaphorin 3B (SEMA3B) Located at Chromosome 3p21.3 Suppresses Tumor Formation in an Adenocarcinoma Cell Line. Cancer Res 2002; 62:542–546.

    PubMed  CAS  Google Scholar 

  86. Martin-Satue M, Blanco J. Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg Oncol Suppl 1999; 72:18–23.

    Article  CAS  Google Scholar 

  87. Fujisawa H, Takagi S, Hirata T. Growth-associated expression of a membrane protein, neuropilin, in Xenopus optic nerve fibers. Dev Neurosci 1995; 17:343–349.

    Article  PubMed  CAS  Google Scholar 

  88. Zhang ZG, Tsang W, Zhang L et al. Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J Cereb Blood Flow Metab 2001; 21:541–549.

    Article  PubMed  Google Scholar 

  89. Ishihama H, Ohbayashi M, Kurosawa N et al. Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy. Invest Ophthalmol Vis Sci 2001; 42:1172–1178.

    PubMed  CAS  Google Scholar 

  90. Ishida S, Shinoda K, Kawashima S et al. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41:1649–1656.

    PubMed  CAS  Google Scholar 

  91. Murohara T, Asahara T, Silver M et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101:2567–2578.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgical Research, Children’s Hospital and Harvard Medical School, Boston, MA, 02115

    Michael Klagsbrun & Roni Mamluk

  2. Departments of Pathology, Children’s Hospital and Harvard Medical School, Boston, MA, 02115

    Michael Klagsbrun

  3. Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita Osaka, 565-0871, Japan

    Seiji Takashima

Authors
  1. Michael Klagsbrun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seiji Takashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roni Mamluk
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Maître de Conférences, Université Louis Pasteur, 67084, Strasbourg, France

    Dominique Bagnard Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Klagsbrun, M., Takashima, S., Mamluk, R. (2002). The Role of Neuropilin in Vascular and Tumor Biology. In: Bagnard, D. (eds) Neuropilin: From Nervous System to Vascular and Tumor Biology. Advances in Experimental Medicine and Biology, vol 515. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0119-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0119-0_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4932-7

  • Online ISBN: 978-1-4615-0119-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation